Every 8-K that Dupont De Nemours Inc (DD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow DD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DD filings page.
DuPont de Nemours, Inc. reported second quarter 2026 results, with net sales of $1.8 billion, up 4% on 4% organic growth, and adjusted EPS from continuing operations of $1.88, up 48% versus a year earlier, while exceeding its second quarter 2026 guidance and raising full‑year 2026 guidance.
GAAP income from continuing operations was $191 million (GAAP EPS $1.37), and operating EBITDA rose to $448 million with a 24.6% margin. Cash provided by operating activities from continuing operations was $400 million, and transaction‑adjusted free cash flow reached $326 million, a 127% conversion. The company plans to repurchase $250 million of shares in the third quarter, now expects full‑year 2026 operating EBITDA of about $1.76 billion and adjusted EPS around $7.24, and has changed its GICS code to Industrials following portfolio moves including the $1.2 billion Aramids business sale and a 1‑for‑3 reverse stock split effective June 24, 2026.
DuPont de Nemours, Inc. implemented a 1-for-3 reverse stock split of its common stock, together with a proportional reduction in the number of authorized common shares. These changes, previously approved by stockholders and the Board, were effected through a Certificate of Amendment to the company’s Third Amended and Restated Certificate of Incorporation.
The Certificate of Amendment became effective at 12:01 a.m. Eastern Time on June 24, 2026, followed one minute later by a restated charter reflecting the amendment. The company’s common stock will continue to trade on the New York Stock Exchange under the ticker symbol DD, with a new CUSIP number 26614N 201.
DuPont de Nemours, Inc. reported results from its 2026 annual meeting and detailed a reverse stock split. Stockholders elected 10 directors, approved executive compensation, ratified PricewaterhouseCoopers LLP as auditor for 2026, and authorized a reverse stock split and corresponding reduction in authorized shares.
The Board has set a 1-for-3 reverse stock split, expected to become effective at 12:01 a.m. Eastern Time on June 24, 2026, after which DuPont shares will trade on a split-adjusted basis on the NYSE under the existing ticker DD. Authorized common shares will be reduced from 1,666,666,667 to 555,555,556, and outstanding shares would have been reduced proportionately from approximately 405,058,202 to 135,019,401 if applied as of May 22, 2026, with cash paid in lieu of fractional shares.
DuPont also reaffirmed its second quarter and full-year 2026 financial guidance and provided split-adjusted adjusted earnings per share targets. For 2Q 2026, adjusted EPS guidance is approximately $1.75 (previously ~$0.59), and for full-year 2026, adjusted EPS guidance is $7.02–$7.16 (previously $2.35–$2.40), based on a projected weighted average diluted share count of about 137 million shares.
DuPont de Nemours reported solid first quarter 2026 results and raised its full-year 2026 outlook. Net sales reached $1.681 billion, up 4% with 2% organic growth, while operating EBITDA rose to $414 million, a 15% increase and a 230 basis point margin expansion to 24.6%.
GAAP income from continuing operations grew to $150 million and GAAP EPS to $0.36, with adjusted EPS rising to $0.55, up 53% from the prior year. Cash provided by operating activities from continuing operations improved to $232 million, supporting transaction-adjusted free cash flow of $147 million.
The Healthcare & Water Technologies segment delivered 6% higher net sales and a 30.3% operating EBITDA margin; Diversified Industrials grew sales 3% with margins up to 22.9%. DuPont completed the $1.2 billion cash sale of its Aramids business plus a $300 million note and $325 million equity stake, and announced a planned $275 million accelerated share repurchase. The company now guides 2026 net sales of $7.155–$7.215 billion, operating EBITDA of $1.73–$1.76 billion, and adjusted EPS of $2.35–$2.40.
DuPont de Nemours, Inc. reported that Luke Kissam resigned from its Board of Directors effective April 14, 2026. He is leaving in connection with his future appointment as Chief Executive Officer of Corteva, Inc. The company stated his departure is not due to any disagreement over operations, policies, or practices. Following his resignation, DuPont’s Board size was reduced from eleven to ten directors.
DuPont de Nemours, Inc. plans a reverse stock split of its common stock, subject to stockholder approval, at a ratio between 1-for-2 and 1-for-4, with the exact ratio to be set later by the Board of Directors.
If implemented, the company will proportionally reduce authorized common shares. DuPont states the reverse split will not affect stockholder voting or other rights, business operations, or outstanding debt. The proposal will be voted on at the Annual Meeting of Stockholders on May 21, 2026, with a record date of March 30, 2026. The Board may delay or abandon the reverse split even if it is approved.
DuPont de Nemours, Inc. reports that it expects to close the previously announced sale of its aramids business, which includes the Kevlar and Nomex product lines, to Arclin on April 1, 2026. All regulatory conditions required to complete the sale were satisfied as of March 10, 2026.
The company notes that statements about the timing and completion of the transaction are forward-looking and subject to various risks, including potential closing conditions, separation impacts and the future performance of the Arclin entity in which DuPont expects to hold a minority interest.
DuPont de Nemours reported flat fourth-quarter 2025 net sales of $1.7 billion, with organic sales down 1% after a timing shift from system cut-over activities. The quarter showed a GAAP loss from continuing operations of $108 million, but operating EBITDA rose 4% to $409 million and adjusted EPS increased to $0.46 from $0.39. Transaction-adjusted free cash flow reached $228 million.
For full year 2025, net sales grew 2% to $6.8 billion, led by 7% organic growth in Healthcare & Water Technologies, partly offset by declines in Diversified Industrials. GAAP income from continuing operations was $98 million versus a prior-year loss, while operating EBITDA rose to $1.63 billion and adjusted EPS climbed 16% to $1.68. Transaction-adjusted free cash flow was $689 million.
The company completed the separation of its Electronics business into Qnity Electronics and is progressing on the planned Aramids divestiture, expected to close around the end of first-quarter 2026. For 2026, DuPont guides to net sales of $7.075–$7.135 billion, operating EBITDA of $1.725–$1.755 billion, and adjusted EPS of $2.25–$2.30, implying continued margin strength and earnings growth.
DuPont de Nemours, Inc. reported that its Board of Directors has appointed D.G. Macpherson to the Board, effective immediately as of January 20, 2026. The Board determined that he qualifies as an independent director under New York Stock Exchange standards, SEC rules, and the company’s Corporate Governance Guidelines.
Macpherson, age 58, is the Chief Executive Officer and Chairman of W.W. Grainger, Inc., having served as CEO since 2016 and Chairman since 2017, following earlier senior operating roles at Grainger. His background also includes leadership at Boston Consulting Group and engineering experience in the U.S. Air Force, supported by degrees from Stanford University and Northwestern’s Kellogg School of Management.
DuPont stated there is no special arrangement or understanding under which he was selected and no related-party transactions requiring disclosure. He will receive DuPont’s standard compensation for non-employee directors. A press release announcing his appointment is included as Exhibit 99.1.
DuPont de Nemours, Inc. reported a technical update related to its agreements following the spin-off of Qnity Electronics, Inc. effective November 1, 2025. DuPont and Qnity have now agreed that DuPont’s “Applicable Percentage” under their Separation and Distribution Agreement is 56%, which resets the “Minimum EBITDA” for DuPont to $1,400,000,000 under a related 2019 letter agreement with Corteva, Inc. They also agreed that Qnity’s Applicable Percentage is 44%. These percentages define how minimum earnings benchmarks are allocated between DuPont and Qnity after the spin-off.
DuPont de Nemours, Inc. entered into a Fifth Supplemental Indenture after successfully completing consent solicitations with holders of its 5.319% Notes due 2038 and 5.419% Notes due 2048. The required consents were received by 5:00 p.m. New York City time on November 7, 2025, and the supplemental indenture became operative on November 19, 2025.
Separately, DuPont reported early results of a cash tender offer for its 5.419% Notes due 2048. On November 19, 2025, the company paid for an aggregate principal amount of $739,256,000 of these 2048 Notes that were validly tendered by November 17, 2025, subject to proration. These steps adjust the terms and outstanding amount of DuPont’s long-dated notes.
DuPont de Nemours, Inc. furnished an 8‑K to announce it issued a press release with its third‑quarter 2025 results. The disclosure appears under Item 2.02 (Results of Operations and Financial Condition) and is being furnished, not filed, which means it is not subject to Section 18 liability and is not incorporated by reference into Securities Act filings.
The filing includes Exhibit 99.1, the press release for Q3 2025, and an Inline XBRL cover page exhibit. The report was signed by the Company’s Vice President of Tax, Controller and Chief Accounting Officer.
DuPont de Nemours, Inc. (DD) announced it has completed the separation of its Electronics business into a new independent public company, Qnity Electronics Inc., effective November 1, 2025. The separation was executed via a pro rata dividend in-kind of all then-issued and outstanding shares of Qnity Electronics Inc. common stock to DuPont stockholders of record as of the close of business on October 22, 2025.
To help investors understand the post-separation company, DuPont furnished unaudited pro forma consolidated financial information, giving effect to the separation and related changes to its capital structure, as Exhibit 99.1. This pro forma information reflects how DuPont’s financials would look after the transaction, aiding comparability going forward. The filing was made under Item 9.01(b) of the Exchange Act.
DuPont de Nemours (DD) completed the spin-off of its Electronics business as Qnity Electronics effective 12:03 a.m. on November 1, 2025, via a pro rata dividend in-kind. Holders of DuPont common stock as of October 22, 2025 received 1 share of Qnity for every 2 shares of DuPont. Qnity begins regular-way trading on the NYSE under the symbol “Q” on November 3, 2025.
To support separation, DuPont and Qnity executed a Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, reciprocal Transition Services Agreements, an IP Cross‑License, and a Legacy Liabilities Assignment Agreement allocating specified legacy obligations. DuPont will disclose the Applicable DuPont Percentage for Minimum EBITDA under the Corteva framework after the distribution.
Debt actions include a special mandatory redemption of $900,000,000 New 2028 Notes, $225,963,000 New 2038 Notes, and $294,781,000 New 2048 Notes. DuPont launched consent solicitations backed by holders of 83.90% of 2038 Notes ($649,403,000) and 60.25% of 2048 Notes ($1,117,709,000), and a tender offer to purchase up to $739,256,000 of 2048 Notes at $1,000 per $1,000 plus accrued interest. Following these steps, DuPont targets repayment of approximately $4.0 billion of senior notes with about $168 million in refinancing expenses. Board size reduced to ten; leadership changes include the Executive Chairman transition to non-executive.
DuPont (DD) approved the tax-free separation of its Electronics business into Qnity Electronics and declared a pro rata stock dividend to complete the spin-off. Shareholders of record on October 22, 2025 will receive one share of Qnity for every two shares of DuPont they hold, with the distribution expected on November 1, 2025. Fractional Qnity shares will be settled in cash.
After the distribution, DuPont shareholders will own 100% of Qnity, which will trade independently on the NYSE. Qnity is expected to trade “when-issued” as Q WI from October 27–31, 2025, and “regular way” as Q starting November 3, 2025. During October 27–31, DuPont will trade both with distribution rights (DD) and ex-distribution (DD WI). Completion remains subject to stated conditions in the final information statement.
DuPont de Nemours, Inc. filed an 8-K reporting supplemental indentures and related debt documentation. The filing lists a Third Supplemental Indenture dated September 15, 2025 and a Fourth Supplemental Indenture dated October 2, 2025 with U.S. Bank Trust Company, National Association as trustee. It includes the forms of notes for three series: 4.725% Notes due 2028, 5.319% Notes due 2038, and 5.419% Notes due 2048. A Registration Rights Agreement dated October 2, 2025 names Citigroup, J.P. Morgan, MUFG and TD Securities as dealer managers. The cover page interactive XBRL is included, and the filing is signed by Erik T. Hoover, Senior Vice President and General Counsel.
DuPont de Nemours, Inc. reported that it has amended its previously announced exchange offers for its outstanding 4.725% Notes due 2028 in the principal amount of $2,250,000,000, 5.319% Notes due 2038 in the amount of $1,000,000,000 and 5.419% Notes due 2048 in the amount of $2,150,000,000.
The company is offering to exchange these existing notes for new notes issued by DuPont and is concurrently conducting consent solicitations from eligible holders of each series to adopt amendments to the relevant indentures. The amended terms are described in a confidential offering memorandum and a related supplement, with additional details contained in a press release attached as an exhibit.
DuPont announced a definitive agreement to sell its Aramids business (Kevlar4 and Nomex4) to Arclin for an enterprise value of approximately $1.8 billion. Under the Transaction Agreement, DuPont will receive roughly $1.2 billion in pre-tax cash at closing (subject to customary adjustments), a $300 million note receivable, and a non-controlling common equity stake in the combined Arclin business currently valued at $325 million, expected to represent about a 17.5% ownership at closing. The agreement is conditioned on customary closing requirements, including regulatory approvals in multiple non-U.S. jurisdictions and satisfactory representations, warranties and performance by the parties.
DuPont agreed to sell its Aramids business (Kevlar® and Nomex®) to Arclin, a portfolio company of an affiliate of TJC, L.P., in a transaction valuing the business at approximately $1.8 billion. At closing DuPont is expected to receive approximately $1.2 billion in pre-tax cash proceeds (subject to customary adjustments), a $300 million note receivable, and a non-controlling common equity stake in the combined Arclin business currently valued at about $325 million (approximately 17.5% at closing). The sale is conditioned on customary closing conditions, including regulatory approvals. The information is disclosed in a press release embedded in the company’s 8-K filing.
DuPont de Nemours (DD) filed an 8-K describing contingent outcomes tied to a planned Spin-Off involving Qnity. The filing states that if the Spin-Off is not consummated by the earlier of March 31, 2026 or the date Qnity notifies parties that the Spin-Off will not occur, or if not completed within two business days of gross proceeds being released from escrow, then the Notes will be subject to a special mandatory redemption. The filing also states that the Unsecured Notes will be jointly and severally and unconditionally guaranteed on a senior unsecured basis by each Qnity subsidiary that is a borrower or guarantor under Qnity's Credit Facilities. The document is signed by Michael G. Goss, Vice President and Controller, dated August 15, 2025.
DuPont de Nemours announced that its wholly owned subsidiary, Qnity Electronics, priced an offering of debt securities consisting of $1.0 billion aggregate principal amount of 5.750% Senior Secured Notes due 2032 and $750 million aggregate principal amount of 6.250% Senior Notes due 2033. The Notes were priced at 100.000% of their principal amount and are being offered under Rule 144A and Regulation S.
The offering is being made in connection with DuPont's previously announced plan to separate its electronics business through a pro rata distribution of Qnity common stock to DuPont stockholders. The offering is expected to close on August 15, 2025, subject to customary closing conditions, and the Notes and related guarantees have not been registered under the Securities Act.
DuPont and its wholly owned subsidiary Qnity Electronics announced an offering of approximately $1.5 billion aggregate principal amount of senior secured notes and $1.0 billion aggregate principal amount of senior unsecured notes, to be offered under Rule 144A and Regulation S. The offering is being made in connection with DuPont's previously announced plan to separate its electronics business by distributing Qnity common stock pro rata to DuPont stockholders. A press release describing the offering is furnished as Exhibit 99.1 and is furnished, not filed, for certain Exchange Act purposes.
On 3 Aug 2025 DuPont (NYSE: DD), Chemours and Corteva agreed to a Judicial Consent Order with the State of New Jersey to resolve all outstanding state claims tied to historic DNAPL, solvent and PFAS contamination at four legacy DuPont sites (Chambers Works, Parlin, Pompton Lakes, Repauno) and alleged statewide PFAS impacts.
Financial terms:
- A combined $875 million cash payment spread over 25 years; first instalment due no sooner than 31 Jan 2026.
- DuPont’s share is estimated at $311 million NPV; a $177 million pre-tax charge was recorded in Q2-25 discontinued operations.
- DuPont will apply its existing $35 million MOU escrow to the 2026 payment.
- DuPont & Corteva will post a separate $475 million surety-backed Reserve Fund to backstop remediation once site-level funding is exhausted.
Additional provisions: DuPont/Corteva will pay $150 million (DuPont $106.5 m) to buy Chemours’ rights to equal PFAS-related insurance proceeds plus a contingent fee. A third-party review could require higher remedial funding sureties, potentially increasing future environmental reserves. Parties may prepay at the settlement discount rate.
The agreement contains no admission of liability, remains subject to public comment and Federal District Court approval, and will offset each party’s annual PFAS MOU escrow obligations.